Table 6 Neonatal outcomes women with active AN during pregnancies are more likely to occur in comparison to women without a history of AN—sorted by categories: growth or development related, medical, and others

Growth or development related

SGA birth [23, 24, 28, 30, 38,39,40]

1.52 (1.35–1.72) [28]

2.1 (1.3–3.6) [23]

2.20 (1.23–3.93) [24]

2.90 (1.98–4.26) [40]

Low birth weight [24, 25, 27,28,29, 39]

1.69 (1.44–1.99) [28]

2.16 (1.30–3.58) [24]

Microcephaly [23]

2.8 (1.5–5.0) [23]

Growth restriction [29]

–

Micropolygria [25]

–

Medical

Cardiovascular disorders [28, 35]

1.27 (1.03–1.56) [28]

Respiratory disorders [28]

1.16 (1.02–1.31) [28]

Metabolic alkalosis [30]

–

Electrolyte imbalances [30]

–

Others

Preterm birth (< 37 weeks) [23, 24, 26,27,28,29, 34, 41]

Premature < 37 weeks: 1.32 (1.13–1.55) [28], 2.0 (1.4–2.9) [23]

Very premature < 28 weeks: 2.0 (1.4–3.0) [23], 4.59 (1.25–16.87) [24]

Perinatal death (stillbirth or death during neonatal period) [24, 28, 35]

1.99 (1.20–3.30) [28]

4.06 (1.15–14.35)[24]

Neonatal Intensive care admission [28, 30]

1.33 (1.09–1.62) [28]